The COLOSSUS Project
Colorectal cancer is the third most common cancer in Europe. COLOSSUS is an EU-funded H2020 project that aims to provide new and more effective ways to classify patients with a specific type of colorectal cancer (microsatellite stable RAS mutant metastatic colorectal cancer or MSS RAS mt mCRC) and to develop better treatments for them. Our ultimate goal is to deliver a personalised medicine approach for patients with MSS RAS mt mCRC that is currently not available.
Project Partners
The COLOSSUS Project brings together a multidisciplinary team of 14 different partners from 8 different countries.
Latest News
Dr Ian Miller, RCSI visits Bon Secours Hospital Cork to promote the COLOSSUS trial and objectives
On Friday, October 11, 2019, Dr Ian Miller, of the RCSI, Royal College of Surgeons in Ireland facilitated a talk at the Bon Secours Hospital in Cork. The purpose of Dr Miller's visit was to [...]
VHIO’s PI Dr Rodrigo Dienstmann presents COLOSSUS at ESMO Congress 2019
During the Special Symposium at ESMO 2019 "Stratified treatment in metastatic colorectal cancer" on 29 September, COLOSSUS PI Dr Rodrigo Dienstmann of Vall d'Hebron Institute of Oncology presented COLOSSUS in his talk entitled "New molecular [...]
Ireland enrols first person in COLOSSUS translational study
Great news! Dr Brian Bird and his team at Bon Secours Hospital in Cork have registered the first person in Ireland to the COLOSSUS prospective translational trial. Congratulations to the clinical research team! https://twitter.com/DrHealeyBird/status/1174771461313224707?s=20